Cited by CrossRef (5)
- Jerome Deval, Zachary A. Gurard-Levin. Opportunities and Challenges in Targeting the Proofreading Activity of SARS-CoV-2 Polymerase Complex. Molecules 2022;27:2918

- Rukesh Chinthapatla, Mohamad Sotoudegan, Pankaj Srivastava, Thomas K Anderson, Ibrahim M Moustafa, Kellan T Passow, Samantha A Kennelly, Ramkumar Moorthy, David Dulin, Joy Y Feng, Daniel A Harki, Robert N Kirchdoerfer, Craig E Cameron, Jamie J Arnold. Interfering with nucleotide excision by the coronavirus 3′-to-5′ exoribonuclease. 2023;51:315

- Thomas D. Gillis, Stephen L. Bearne. Effects of the 5′‐Triphosphate Metabolites of Ribavirin, Sofosbuvir, Vidarabine, and Molnupiravir on CTP Synthase Catalysis and Filament Formation: Implications for Repurposing Antiviral Agents against SARS‐CoV‐2. ChemMedChem 2022;17

- Tuhin Mukherjee, Payel Mal, Abhay Kumar Upadhyay, Satyajit Mohanty, Nikita Nayak, Ravi Pratap Singh, Ashok Pattnaik, Tanisha Das, Sourav Basak. Safety Profile of Molnupiravir with Significant Effect on COVID-19: A
Review. CDTH 2023;18:183

- Trang T. X. Huynh, Thuy X. Pham, Gun-Hee Lee, Jae-Bong Lee, Sung-Geun Lee, Dongseob Tark, Yun-Sook Lim, Soon B. Hwang, Donna M. Neumann. Amuvatinib Blocks SARS-CoV-2 Infection at the Entry Step of the Viral Life Cycle. Microbiol Spectr 2023;11
